| | | | | |
AGIO Agios Pharmaceuticals, Inc. | €23.8392 | +4.40% | €1.50B | €439.87K | |
SGRY Surgery Partners, Inc. Common Stock | €11.6289 | -0.07% | €1.50B | €968.38K | |
GAB The Gabelli Equity Trust Inc. | €4.8283 | -0.09% | €1.50B | €654.77K | |
HURN Huron Consulting Group Inc. | €90.2360 | -0.05% | €1.49B | €142.59K | |
ENVX Enovix Corporation Common Stock | €7.0807 | -0.12% | €1.49B | €5.50M | |
PAYO Payoneer Global Inc. Common Stock | €4.3802 | -0.10% | €1.49B | €3.27M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | €12.8435 | +0.00% | €1.49B | €138.27K | |
STGW Stagwell Inc. Class A Common Stock | €5.6766 | +0.00% | €1.49B | €1.33M | |
CASH Pathward Financial, Inc. Common Stock | €66.9136 | -0.08% | €1.49B | €246.52K | |
SNDX Syndax Pharmaceuticals, Inc. | €15.8024 | +0.03% | €1.49B | €704.81K | |
STRA Strategic Education, Inc. Common Stock | €68.0851 | -0.01% | €1.49B | €117.51K | |
CAPR Capricor Therapeutics Inc | €23.8349 | +0.11% | €1.49B | €461.51K | |
AAPG Ascentage Pharma Group International American Depository Shares | €15.3545 | -3.39% | €1.49B | €19.06K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | €7.0549 | +0.00% | €1.49B | €6.02M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | €21.5350 | +0.04% | €1.49B | €201.19K | |
